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TO THE EDITOR
A mammary gland is a speciﬁc type
of apocrine gland located in the sub-
cutaneous fat of the breast (Ackerman
et al., 2007). The interaction between
receptor of activator nuclear factor
kappa-B (RANK) and its ligand RANKL
is the main mediator of progesterone-
induced proliferation of mammary
epithelial cells, and the activation of
this pathway promotes mammary
tumorigenesis (Bhatia et al., 2005;
Gonzalez-Suarez, 2011). Extramammary
Paget’s disease (EMPD) is an un-
common adenocarcinoma of apocrine
origin. It usually affects older patients
and is highly metastatic to other organs,
including bone (Shiomi et al., 2013).
On the basis of these ﬁndings, we
hypothesized that the interaction
between RANK and RANKL has a role
in the tumorigenesis of EMPD.
To test this hypothesis, we collected
archival formalin-ﬁxed parafﬁn-
embedded skin specimens and cryosec-
tions from EMPD patients (Supple-
mentary Table S1 and S2 online) for
immunohistochemical and immuno-
ﬂuorescence analysis. This study was
approved by the ethics committee of
Tohoku University Graduate School ofAccepted article preview online 27 May 2015; published online 18 June 2015
Abbreviations: Arg1, arginase 1; DC, dendritic cell; EMPD, extramammary Paget’s disease; LC,
Langerhans cell; MMP-7, matrix metalloprotease-7; RANK, receptor of activator nuclear factor kappa-B;
Treg, regulatory T cell
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Medicine, Sendai, Japan (2013-1-521),
and all patients gave written informed
consent. The antibodies and antigen
retrieval methods used are described in
Supplementary Table S3 online. For laser
capture microdissection, three samples of
EMPD tissue and surrounding normal
skin tissue were collected at the time of
resection. For the preparation of samples
for tissue culture, three samples of EMPD
tissue and surrounding normal skin tissue
were obtained and cultured in complete
medium for 7 days. Full details are
available in the Supplementary Methods
online.
Figure 1 shows that Paget cells strongly
expressed RANKL (Figure 1a–c and
Supplementary Table S1 online) and the
matrix metalloprotease (MMP)-7, which
cleaves RANKL to release a soluble form
(sRANKL), (Figure 1d–f and Supplemen-
tary Table S1 online) on their surface
(Lynch et al., 2005). Notably, keratino-
cytes of either lesional or normal epider-
mis did not express RANKL or MMP-7
(Figure 1a and d, and Supplementary
Figure S1A online), whereas there
were several RANKL-expressing stromal
cells scattered in the lesional dermis
(Figure 1c). In addition, apocrine glands
in the lesional skin of EMPD expressed
RANKL and MMP-7 (Supplementary
Figure S1B and S1C online), whereas
apocrine glands in normal skin did not
express MMP-7 (Supplementary Figure
S1D online).
To analyze the mRNA expression of
RANKL and MMP-7 by EMPD, we
performed quantitative real-time reverse
transcriptase–PCR using mRNA recov-
ered from the laser-captured epidermis
from the lesional skin containing Paget
cells and that from the uninvolved
skin of three cases of EMPD (Figure 1g
and h and Supplementary Figure S1E
online). The expression of RANKL
mRNA (Figure 1g) and MMP-7 mRNA
(Figure 1h) was signiﬁcantly more
abundant in the lesional epidermis of
EMPD, suggesting the expression of
RANKL and MMP-7 mRNA by Paget
cells. As MMP-7 expression by Paget
cells suggested that they might release
sRANKL into the extracellular space of
the lesional skin of EMPD, we cultured
the lesional and non-lesional skin of
EMPD and measured the concentration
of sRANKL in the culture supernatants
using ELISA. The results clearly demon-
strated that the culture supernatants of
the lesional skin contained signiﬁcantly
more sRANKL compared with those of
the non-lesional skin (Figure 1i). These
results indicate that the extracellular
space surrounding EMPD tissue is rich
in sRANKL.
To clarify the signiﬁcance of RANKL
expression by Paget cells, we immuno-
histochemically stained cryosections of
EMPD tissue for RANK. RANK was not
expressed by Paget cells or surrounding
keratinocytes but was instead expressed
on scattered dermal cells (Figure 2a),
as well as on epidermal dendritic cells
(DCs; Figure 2a insert). In addition,
RANK mRNA expression in the lesional
epidermis of EMPD was lower than that
in the non-lesional epidermis, which
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Figure 1. Extramammary Paget’s disease lesions, both noninvasive and invasive, express receptor of activator nuclear factor kappa-B ligand and matrix
metalloprotease-7. Immunohistochemical staining for RANKL (a–c) and MMP-7 (d–f). Scale bar= 100 μm. The expression of RANKL mRNA (g) and MMP-7
mRNA (h) in laser-captured epidermis of EMPD was analyzed by quantitative RT-PCR, using the ΔΔCt method. The mean± SEM of data from three cases of
EMPD and non-lesional skin is presented. The production of sRANKL from EMPD tissue culture was measured using ELISA (i). *Po0.05 by Student’s t-test
(g–i). RT-PCR, reverse transcriptase–PCR.
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supported the immunohistochemical
demonstration of the lack of RANK
expression by Paget cells (Supplemen-
tary Figure S1F online). Although it is
well known that epidermal Langerhans
cell (LC)s express RANK (Loser et al.,
2006), the origin of the RANK+ cells
scattered in the dermis has not yet
been clariﬁed. When we immunohisto-
chemically stained the lesional skin
of EMPD with several antibodies
against macrophages and DCs such as
anti-CD163 Ab (Figure 2b), anti-CD1a
Ab, anti-CD205 Ab, or anti-CD208
Ab (data not shown), the distribution
of the cells expressing CD163 appeared
to overlap with that of dermal RANK+
cells (Figure 2b).
Therefore, to clarify the origin of the
RANK+ dermal cells, we conducted
double immunoﬂuorescence staining
of cryosections with combinations of
antibodies against RANK and CD163
(Figure 2c), against RANK and CD3
(Figure 2d), against CD163 and CD206
(Figure 2e), and against CD163 and
arginase 1 (Arg1; Figure 2f). The average
expression of RANK on CD163+ macro-
phages and that of CD163 on RANK+
cells was 48% and 62%, respectively
(Figure 2c, Supplementary Table S2
online). There were a few CD3+ cells
that co-expressed RANK (Figure 2d).
Moreover, CD163+ macrophages sur-
rounding EMPD expressed both CD206
(Figure 2e) and Arg1 (Figure 2f), which
suggests that these CD163+ macro-
phages including RANK-expressing cells
are M2 macrophages (Hao et al., 2012).
We have demonstrated here that
RANK is mainly expressed by CD163+
Arg1+ CD206+ macrophages, suggest-
ing that the sRANKL released from Paget
cells stimulates these macrophages via
RANK. The role of these macrophages
in EMPD remains to be clariﬁed.
Accumulating evidence has suggested
that RANKL-mediated modulation of
surface barrier DCs including LCs
results in the suppression of autoim-
mune responses and of detrimental
immune responses toward self-antigen,
as well as innocuous foreign antigen. As
an explanation of this phenomenon, it
was reported that RANKL-stimulated
LCs induce the expansion of regulatory
T cells (Tregs) in UV-irradiated skin
(Loser et al., 2006). We previously
reported that a signiﬁcant number of
both M2 macrophages and Tregs
inﬁltrate EMPD lesions (Fujimura et al.,
2012; Fujimura et al., 2013). However,
the interaction between Tregs and these
macrophages in EMPD was unclear.
Press et al. (2011) suggested that
increased Tregs are associated with
more extensive cases of vulvar EMPD
and disease recurrence. Similarly,
breast cancers with a high risk for
recurrence are accompanied by the
recruitment of greater numbers of
Tregs to the tumor microenvironment
(Bates et al., 2006). Moreover, a high
expression level of CD163 on tumor-
associated macrophages in breast can-
cer is associated with reduced overall
survival and reduced recurrence-free
survival (Medrek et al., 2012). These
studies suggested that both Tregs and
macrophages have a crucial role in
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Figure 2. CD163+ CD206+ Arg1+M2 macrophages express RANK in the lesional skin of extramammary
Paget’s disease. Immunohistochemical staining of EMPD for RANK (a) and CD163 (b). Double
immunoﬂuorescence staining of EMPD for CD163 and RANK (c) (red: CD163, green: RANK, blue: DAPI,
yellow: merge), for CD3 and RANK (d) (red: CD3, green: RANK, blue: DAPI, yellow: merge), for CD163
and CD206 (e) (red: CD163, green: CD206, blue: DAPI, yellow: merge), and for CD163 and Arg1
(f) (red: CD163, green: Arg1, blue: DAPI, yellow: merge). Scale bar=100 μm (a and b) and 40 μm (c–f).
Arg1, arginase 1; RANKL, receptor of activator nuclear factor kappa-B ligand.
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constituting the immunosuppressive
microenvironment that causes poor
prognosis in EMPD, as well as in
breast cancer. In the accompanying
paper, we demonstrate a role for
RANKL-stimulated macrophages in
recruiting Tregs into the skin.
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Th2 Cytokines Suppress Lipoteichoic Acid–Induced Matrix
Metalloproteinase Expression and Keratinocyte Migration
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TO THE EDITOR
Recent clinical trials have established a
central role for the T helper type 2 (Th2)
cytokines IL-4 and IL-13 in the pathol-
ogy of atopic dermatitis (AD) (Beck
et al., 2014). Although blockade of the
IL-4 and IL-13 receptors causes signiﬁ-
cant clearing of skin lesions, a direct
effect of Th2 cytokines on wound
healing processes has not yet been
demonstrated. Furthermore, AD patients
are frequently affected by infection with
the pathogen, Staphylococcus aureus
(Boguniewicz and Leung, 2011).
Elevated levels of staphylococcal
products are frequently found on the
skin of affected patients (Travers et al.,
2010), and these products may affect
the wound healing process as well.
A primary event in skin healing is
induction of matrix metalloproteinases
(MMPs) (Inoue et al., 1995). MMPs-1,
-9, and -10 are expressed at the leading
edge of the wound (Inoue et al., 1995;
Rechardt et al., 2000; Turchi et al.,
2003) and are required for keratino-
cyte migration into the damaged area
(Pilcher et al., 1997; Agren, 1999). Inhi-
bition of MMP function effectively
blocks keratinocyte migration and
wound healing (Mirastschijski et al.,
2002b). However, overexpression of
MMPs has been reported in skin dis-
eases and can inhibit wound closure as
well (Saarialho-Kere et al., 1994;
Mirastschijski et al., 2002a). In this
study, we determined the effects of
staphylococcal products and AD-
associated Th2 cytokines on MMP
expression and on keratinocyte
migration.
We ﬁrst examined the effect of
bacterial products on MMP levels.Accepted article preview online 7 May 2015; published online 28 May 2015
Abbreviations: AD, atopic dermatitis; LTA, lipoteichoic acid; MMP, matrix metalloproteinase;
siRNA, small interfering RNA; STAT6, signal transducer and activator of transcription 6;
Th2, T helper type 2; TIMP, tissue inhibitor of metalloproteinase; TNF-α, tumor necrosis factor-α
AM Brauweiler et al.
Th2 Cytokines Suppress Keratinocyte Migration
2550 Journal of Investigative Dermatology (2015), Volume 135
